Ghent University Academic Bibliography

Your filters: cql: author="Sanders, Joyce" or (type any "bookEditor issueEditor" and editor="Sanders, Joyce")

Add to list
Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)

S Lot Aronson, Cédric Walker, Bram Thijssen, Koen Van de Vijver (UGent) , Hugo M Horlings, Joyce Sanders, Maartje Alkemade, Simone N Koole, Marta Lopez-Yurda, Christianne A R Lok, et al.

(2024) BRITISH JOURNAL OF CANCER. 131. p.565-576
Add to list
- Journal Article
- A1
- open access
Homologous recombination deficiency and cyclin E1 amplification are correlated with immune cell infiltration and survival in high-grade serous ovarian cancer

Lilian van Wagensveld, Juliette O A M van Baal, Maite Timmermans, Duco Gaillard, Lauri Borghuis, Seth B Coffelt, Efraim H Rosenberg, Christianne A R Lok, Hans W Nijman, Loes F S Kooreman, et al.

(2022) CANCERS. 14(23).
Add to list
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer : results from the phase III OVHIPEC trial

Simone N. Koole, Philip C. Schouten, Jan Hauke, Roel J. C. Kluin, Petra Nederlof, Lisa K. Richters, Gabriele Krebsbach, Karolina Sikorska, Maartje Alkemade, Mark Opdam, et al.

(2022) INTERNATIONAL JOURNAL OF CANCER. 151(8). p.1394-1404
Add to list
Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy

Leonora de Boo, Ashley Cimino-Mathews, Yoni Lubeck, Antonios Daletzakis, Mark Opdam, Joyce Sanders, Erik Hooijberg, Annelot van Rossum, Zuzana Loncova, Dietmar Rieder, et al.

(2020) European Journal of Cancer. 127. p.240-250
Add to list
Discordant marker expression between invasive breast carcinoma and corresponding synchronous and preceding DCIS

Lindy L. Visser, Lotte E. Elshof, Koen Van de Vijver (UGent) , Emma J. Groen, Mathilde M. Almekinders, Joyce Sanders, Carolien Bierman, Dennis Peters, Ingrid Hofland, Annegien Broeks, et al.

(2019) The American Journal of Surgical Pathology. 43(11). p.1574-1582
Add to list
- Journal Article
- A1
- open access
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Marcelo Sobral-Leite, Izhar Salomon, Mark Opdam, Dinja T. Kruger, Karin J. Beelen, Vincent van der Noort, Ronald L. P. van Vlierberghe, Erik J. Blok, Daniele Giardiello, Joyce Sanders, et al.

(2019) Breast Cancer Research. 21(1).
Add to list
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

Marcelo Sobral-Leite, Koen Van de Vijver (UGent) , Magali Michaut, Rianne van der Linden, Gerrit K.J. Hooijer, Hugo M. Horlings, Tesa M. Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, et al.

(2018) OncoImmunology. 7(12).
Add to list
- Journal Article
- A1
- open access
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Roger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, Jonathan Beesley, Siddhartha Kar, Sara Lindström, Shirley Hui, Audrey Lemaçon, Penny Soucy, Joe Dennis, et al.

(2017) NATURE GENETICS. 49(12). p.1767-1778

Academic Bibliography

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)

Homologous recombination deficiency and cyclin E1 amplification are correlated with immune cell infiltration and survival in high-grade serous ovarian cancer

Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer : results from the phase III OVHIPEC trial

Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy

Discordant marker expression between invasive breast carcinoma and corresponding synchronous and preceding DCIS

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Contents

Support

Contact